Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 3, 2013

View Archived Issues

Epizyme presents novel epigenetic-targeted, small-molecule anticancer agents

Researchers present updated results for CART-19 cell therapy

Exploration of a key mechanistic pathway of antiapoptotic signaling in multiple myeloma

German and U.S. researchers design novel transgenic rat model for Huntington's disease

Novel agents for heart failure presented by German researchers

Novo Nordisk discloses new ligands binding to IL-21

New labeled NMDA receptor ligands patented by group in The Netherlands

Merz Pharma presents novel NMDA glycine B receptor antagonists

Novel monoclonal antibodies divulged by Antitope

Theravance synthesizes new series of neprilysin inhibitors

TRU-016 receives orphan medicinal product designation in Europe for CLL

Probuphine obtains FDA priority review designation for opioid dependence

Synergy Pharmaceuticals reports data from phase IIb/III plecanatide trial

Phase II SGI-110 trial begins in hepatocellular carcinoma

Photocure receives payment for Lumacan from Salix Pharmaceuticals

AbbVie launched as independent biopharmaceutical company

Phase IIb data presented for vaccine against enterotoxigenic bacteria

Small-molecule FADK inhibitor demonstrates efficacy for brain cancers

Results from a first-in-human phase I trial presented for AR-42

Kareus Therapeutics announces commencement of phase I trial for Alzheimer's disease candidate

Nexavar meets primary endpoint in RAI-refractory differentiated thyroid cancer

Clinical hold lifted for OncoMed's demcizumab

FDA deems complete Merck & Co's resubmission of NDA for ezetimibe/atorvastatin tablets

Relypsa reaches agreement with FDA for phase III trial of patiromer

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 12, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...